Article
In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates.
The Journal of antimicrobial chemotherapy - 1 Apr 2003
Kim Mi-Jeong, Yun Hee-Jeong, Kang Jin-Wook, Kim Sunghoon, Kwak Jin-Hwan, Choi Eung-Chil
Abstract excerpt
In vitro development of resistance to a novel fluoroquinolone, DW286, as well as to ciprofloxacin, gemifloxacin, sparfloxacin and trovafloxacin, was investigated in eight methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates. The strains were subcultured in subinhibitory concentrations of each agent during a 50 day period. Subculturing in most agents led to the selection of 37 mutants with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
